Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.

Date publication

janvier 2017

Journal

PloS one

Auteurs

Membres identifiés du Cancéropôle Est :
Dr HENROT Philippe

Tous les auteurs :
Oldrini G, Huertas A, Renard-Oldrini S, Taste-George H, Vogin G, Laurent V, Salleron J, Henrot P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28441447

Résumé

To evaluate the MRI features of a tumor response, local control, and predictive factors of local control after stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC).

Mots clés

Aged, Aged, 80 and over, Carcinoma, Hepatocellular, diagnostic imaging, Disease Progression, Female, Humans, Liver, diagnostic imaging, Liver Neoplasms, diagnostic imaging, Magnetic Resonance Imaging, Male, Middle Aged, Radiosurgery, methods, Response Evaluation Criteria in Solid Tumors, Retrospective Studies, Treatment Outcome

Référence

PLoS ONE. 2017 ;12(4):e0176118